Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
First CT characteristic appearance of patients with coronavirus disease 2019
Wei Nie1, Zhichao Feng2, Xiaowen Mao3
1Department of Radiology, Third Xiangya Hospital, Central South University, Changsha 410013 nieweidaisyn@aliyun.com.
Insights
The first chest CT scans of COVID-19 patients reveal characteristic ground-glass opacities and consolidation patterns. Combining these imaging features with nucleic acid tests aids in accurate diagnosis of SARS-CoV-2 infection.
Area of Science:
- Radiology
- Infectious Diseases
- Pulmonology
Background:
- Coronavirus disease 2019 (COVID-19) is a significant global health concern.
- Accurate and timely diagnosis is crucial for managing COVID-19 patients and controlling its spread.
- Chest computed tomography (CT) is a key imaging modality for evaluating respiratory illnesses.
Purpose of the Study:
- To identify and characterize the specific imaging features of COVID-19 on initial chest CT examinations.
- To establish the correlation between CT findings and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid test results.
- To provide evidence supporting the diagnostic utility of chest CT in COVID-19.
Main Methods:
- Retrospective analysis of imaging and clinical data from 163 COVID-19 patients across two hospitals.
- Detailed examination of the first chest CT scans for lesion characteristics, distribution, and patterns.
- Comparison of CT manifestations with SARS-CoV-2 nucleic acid test results and clinical data.
Main Results:
- Ground-glass opacity (GGO) was observed in 92.02% of patients, consolidation in 76.69%, and combined GGO with consolidation in 73.62%.
- Multiple lesions and lobules were common (71.17% and 86.50%, respectively).
- Specific patterns like bronchial inflation signs (53.37%) and "crazy paving" (36.20%) were noted; hilar lymphadenopathy and pleural effusion were infrequent.
Conclusions:
- Initial chest CT examinations in COVID-19 patients demonstrate distinct imaging features.
- Integrating chest CT findings with SARS-CoV-2 nucleic acid testing, and re-evaluation when needed, enhances diagnostic accuracy for SARS-CoV-2 infection.
Objectives:
To investigate imaging features of the coronavirus disease 2019 (COVID-19), and to provide concrete evidences for diagnosis of COVID-19.
Methods:
Imaging data of the first chest CT examination and clinical data (age, sex, clinical history, epidemiological history, and laboratory tests) of 163 patients with COVID-19 from 2 hospitals were collected for retrospective analysis. Imaging features of the first chest CT examination and the correspondence between CT manifestations and the nucleic acid test results of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were analyzed.
Results:
The first chest CT images of 163 COVID-19 patients showed that 92.02% of lesions were ground-glass opacity (GGO), 76.69% were consolidation, and 73.62% were GGO together with consolidation. Multiple lesions were found in 71.17% patients and multiple lobules in 86.50% patients. Lesions in 53.37% patients were found with bronchial inflation signs and those in 36.20% patients presented with "crazy paving" pattern, while only 7.36% were found with hilar node enlargement and pleural effusion. First CT findings of 18 patients were found to be inconsistent with the results of pathogen examination.
Conclusions:
COVID-19 patients showed specific features in the first chest CT examination. The combination of the first chest CT imaging features and SARS-CoV-2 nucleic acid test results as well as reexamination if necessary can help to make the diagnosis of SARS-CoV-2 infection accurately.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020